Ellie Collins
In aid of three Oxfordshire-based charities, three employees of HealthScience communications consultancy Oxford PharmaGenesis scaled the three highest peaks in England, Scotland and Wales within 24 hours comprising the Trifecta 3Peaks Challenge.
Read MoreWho is publishing their clinical trial results? Do biopharmaceutical industry sponsors carry an unfair burden of the blame for the under-reporting of clinical trial results?
Read MoreAfter more than 2 years of hard work, Aston & Cote Summer Fete (held on 22 June) was the perfect event for Aston & Cote Community Trust to celebrate the opening of a new playground for the young children of the village.
Read MoreLeading medical journals restrict access to industry-funded research, shows a study conducted by researchers at Oxford PharmaGenesis, published in BMJ Open today. This is likely to impede further research and delay patient benefit.
Read More
It’s official – Oxford PharmaGenesis is a great place to work on both sides of the Atlantic! At the end of 2018, we won the award in our US office, and today we are proud to announce that we have also received the award in the UK, with 89% of employees rating the company a […]
Read More
The world-leading, independent HealthScience communications consultancy Oxford PharmaGenesis is celebrating its second Queen’s Award for Enterprise, the UK’s highest accolade for business success.
Read More
Oxford PharmaGenesis Inc., the independent, global HealthScience communications consultancy, is proud to announce that Kevin Ryder has joined their expanding US team as Vice President, Medical Services.
Read More
I was diagnosed with a 60 mm invasive lobular tumour in my left breast (estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 [HER2] negative) without lymph node involvement in June 2015. Fortunately, I found the lump myself (in between mammograms) and was able to get it detected quickly.
Read More
The contemporary era of healthcare has seen changes in the role of the patient. It used to be that patients were perceived as passive receivers of healthcare, but this has altered; the pharmaceutical industry and healthcare professionals are increasingly giving patients a voice and a role in decisions about their healthcare.
Read More
Now over 250 strong, the award-winning, independent HealthScience communications consultancy Oxford PharmaGenesis is pleased to announce the appointment of Corin Wing as Principal Medical Writer.
Read More